Methylcobalamin is a directly usable form of vitamin B12. It reliably corrects and prevents deficiency and lowers homocysteine, and is cheap, safe, and easy to monitor. Claims that this active form beats the cheaper standard form, or helps already-healthy people with energy, mood, or aging, remain largely unproven. (Full Review)

Protocol

Dose

500–1,000 µg

Oral daily for general supplementation or mild deficiency

Timing

Morning

Aligns with energy effects and avoids sleep disruption

Route

Oral

Sublingual or injectable for malabsorption or significant deficiency

Time to effect

B12 status

Weeks

Serum B12 restored to sufficient range

Functional markers

1–3 months

Homocysteine and methylmalonic acid normalize

Neuropathy symptoms

Weeks–months

Symptomatic improvement in neuropathy trials

Benefits

High: Correction and prevention of vitamin B12 deficiency; lowering of elevated homocysteine

Medium: Improvement in diabetic and peripheral neuropathy; relief of neuropathic pain

Low: Support of cognitive function in deficiency or high homocysteine; modulation of methylation and redox markers

Speculative: Longevity and healthy-aging benefit via methylation support; energy and mood in non-deficient individuals

Contraindications

Known cobalt or cobalamin allergy

Key Interactions

Metformin

Proton-pump inhibitors and H2 blockers (omeprazole, esomeprazole, ranitidine, famotidine)

Colchicine and certain antibiotics (chloramphenicol, neomycin)

Nitrous oxide

Folic acid and folate

Vitamin C (high dose)

Risk & Side Effects

Medium: Masking of folate deficiency; injection-site and hypersensitivity reactions

Low: Acne or rosacea-like eruptions; behavioral activation in susceptible individuals

Speculative: Elevated B12 levels as a marker of disease risk; theoretical concerns with very-high-dose long-term use

Monitoring

Marker	Target	Why
Serum Vitamin B12	>400–500 pg/mL	Confirms repletion
Methylmalonic acid (MMA)	Low-normal (<270 nmol/L)	Functional B12 status; rises when B12 is low
Homocysteine	6–8 µmol/L	Tracks methylation/B-vitamin sufficiency
Serum Folate	Mid-to-upper normal	Detects co-existing folate deficiency
Complete Blood Count (MCV)	Normal MCV, no macrocytosis	Detects/monitors anemia

Cadence: Baseline, then 8–12 weeks after starting or changing dose, then every 6–12 months on maintenance

Qualitative Assessment

Energy levels and resolution of unexplained fatigue
Cognitive clarity, memory, and concentration
Numbness, tingling, or nerve pain (improvement or worsening)
Mood and sleep quality
Tongue soreness or mouth changes that can accompany deficiency

Methylcobalamin for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment